Literature DB >> 15617518

In vivo induced antigen technology (IVIAT).

Sean M Rollins1, Amanda Peppercorn, Long Hang, Jeffrey D Hillman, Stephen B Calderwood, Martin Handfield, Edward T Ryan.   

Abstract

In vivo induced antigen technology (IVIAT) is a technique that identifies pathogen antigens that are immunogenic and expressed in vivo during human infection. IVIAT is complementary to other techniques that identify genes and their products expressed in vivo. Genes and gene pathways identified by IVIAT may play a role in virulence or pathogenesis during human infection, and may be appropriate for inclusion in therapeutic, vaccine or diagnostic applications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15617518     DOI: 10.1111/j.1462-5822.2004.00477.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  21 in total

1.  Proteomics-based expression library screening (PELS): a novel method for rapidly defining microbial immunoproteomes.

Authors:  Indira T Kudva; Bryan Krastins; Haiqing Sheng; Robert W Griffin; David A Sarracino; Phillip I Tarr; Carolyn J Hovde; Stephen B Calderwood; Manohar John
Journal:  Mol Cell Proteomics       Date:  2006-05-31       Impact factor: 5.911

2.  Identification of Salmonella enterica serovar Pullorum antigenic determinants expressed in vivo.

Authors:  Qiuchun Li; Yachen Hu; Jing Chen; Zhicheng Liu; Jun Han; Lin Sun; Xinan Jiao
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

3.  Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.

Authors:  Patrick D Vigil; Christopher J Alteri; Harry L T Mobley
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

4.  Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technology.

Authors:  Richelle C Charles; Alaullah Sheikh; Bryan Krastins; Jason B Harris; M Saruar Bhuiyan; Regina C LaRocque; Tanya Logvinenko; David A Sarracino; Indira T Kudva; Jana Eisenstein; Michael J Podolsky; Anuj Kalsy; W Abdullah Brooks; Albrecht Ludwig; Manohar John; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2010-06-23

5.  Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT).

Authors:  Peter E Kima; J Alfredo Bonilla; Eumin Cho; Blaise Ndjamen; Johnathan Canton; Nicole Leal; Martin Handfield
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

Review 6.  Exploiting cholera vaccines as a versatile antigen delivery platform.

Authors:  Anisia J Silva; Francis O Eko; Jorge A Benitez
Journal:  Biotechnol Lett       Date:  2007-11-16       Impact factor: 2.461

7.  Salmonella enterica highly expressed genes are disease specific.

Authors:  Claudia Rollenhagen; Dirk Bumann
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

Review 8.  Bacillus anthracis physiology and genetics.

Authors:  Theresa M Koehler
Journal:  Mol Aspects Med       Date:  2009-08-03

9.  Novel Diagnosis of Lyme Disease: Potential for CAM Intervention.

Authors:  Aristo Vojdani; Frank Hebroni; Yaniv Raphael; Jonathan Erde; Bernard Raxlen
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-15       Impact factor: 2.629

10.  Use of in vivo-induced antigen technology (IVIAT) for the identification of Streptococcus suis serotype 2 in vivo-induced bacterial protein antigens.

Authors:  Hongwei Gu; Haodan Zhu; Chengping Lu
Journal:  BMC Microbiol       Date:  2009-09-18       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.